Record Details

Scientometric study of global mucormycosis (black fungus) research

NOPR - NISCAIR Online Periodicals Repository

View Archive Info
 
 
Field Value
 
Title Scientometric study of global mucormycosis (black fungus) research
 
Creator LR, Rahul
P, Nishy
 
Subject Black Fungus
Mucormycosis
Scientometric
Research Trends
 
Description 376-388
Mucormycosis, a rare infection, caught the attention during the COVID-19 pandemic. Many COVID-19 and postCOVID-19
patients were infected by the black fungus. This study presents a scientometric review of 6661 research articles
related to mucormycosis published from 1947 to 2021 indexed in Scopus and Web of Science. The study analyses the
publications quantitatively in terms of growth, collaboration, countries, institutions, journals, keywords, and impact
(citation) using the Bib-Excel and visualized in the VOSviewer tool. The highest number of publications on mucormycosis
research is from the USA, followed by India, China, Germany, France, and Japan. Most of the research collaborations are
among institutions in Europe and the USA. The University of Texas-USA is the most productive institute followed by
PGIMER-India. However, the papers from Indian institutes have a significantly lower citation impact than those from the
other leading countries. Since most international research is restricted among a few institutes, the international collaboration
in mucormycosis research needs to be enhanced for high-quality research. The analysis of author-assigned keywords showed
that the studies on the drug isavuconazole to treat mucormycosis are lesser than other major drugs. The research on surgical
management of mucormycosis can be improved. Research on the diagnosis methods for mucormycosis and the genetic
studies on the causative fungi of the order Mucorales are to be promoted. There are a few studies on Rhizomucor,
Lichtheimia, Cunninghamella, Saksenaea, and Apophysomyces, among the several fungi genera that cause mucormycosis.
Since mucormycosis is becoming more prevalent and severely affecting a larger population as a post-COVID syndrome,
research in this area should be strengthened and new drugs should be explored.
 
Date 2021-12-24T10:06:39Z
2021-12-24T10:06:39Z
2021-12
 
Type Article
 
Identifier 0975-2404 (Online); 0972-5423 (Print)
http://nopr.niscair.res.in/handle/123456789/58721
 
Language en
 
Publisher NIScPR-CSIR, India
 
Source ALIS Vol.68(4) [December 2021]